← Back
$HALO All transactions

HALOZYME THERAPEUTICS, INC.

A

$ Value

$0

Shares

5,750

Price

$0

Filed

May 2

Insider

Name

Posard Matthew L.

Title

CIK

0001543792

Roles

Director

Transaction Details

Transaction Date

2025-05-01

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

5,750

Footnotes

Represents annual restricted stock unit ("RSU") grant under the Issuer's director compensation program. Each RSU represents the right to receive one share of common stock of the Issuer. This grant will vest in full on the earlier of (i) May 1, 2026 and (ii) the date of the Issuer's next annual meeting of stockholders. These stock units are subject to a written deferral election under the Issuer's Directors Deferred Equity Compensation Plan pursuant to which shares of common stock are released to the reporting person following completion of service as a director. | Represents annual stock option grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 1, 2026 and (ii) the date of the Issuer's next annual meeting of stockholders.

Filing Info

Accession No.

0001415889-25-011777

Form Type

4

Issuer CIK

0001159036

Posard Matthew L.'s History

Date Ticker Type Value
2025-06-23 NAUT A $0
2025-05-01 HALO A $0
2025-05-01 HALO A $0

Other Insiders at HALO (90d)

Insider Bought Sold Last
RAMSAY DAVID A
Interim CFO
2026-04-01
Torley Helen
PRESIDENT AND CEO
$3.2M 2026-04-06